Skip to main content

Ikarian Capital, LLC

Position in OVID — Ovid Therapeutics Inc.

CIK 1778253 DALLAS, TX

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,105,503
-$320,739 QoQ
Shares Held
2,269,704
-21.6% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#16
of 131 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Derivatives in OVID

reported options exposure · as of Sep 30, 2020
CallValue
$91,840
CallShares
16,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. OVID ranks #31 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OVID

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,105,503 2,269,704
2026-03-31 $6,426,242 2,894,704
2025-12-31 $403,519 247,558
2025-09-30 $1,424,246 1,095,574
2022-06-30 $57,686 26,831
2022-03-31 $2,318,488 738,372
2021-12-31 $2,263,313 705,082
2021-09-30 $3,713,075 1,105,082
2021-06-30 $4,398,249 1,124,872
2021-03-31 $4,521,985 1,124,872
2020-09-30 $91,840 16,000
2020-03-31 $1,125,656 377,737